We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+15.81%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$603M
AUM Growth
-$8.68M
Cap. Flow
-$46.2M
Cap. Flow %
-7.66%
Top 10 Hldgs %
7.77%
Holding
1,678
New
527
Increased
200
Reduced
321
Closed
629

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$7.12M
2
GOTU icon
Gaotu Techedu
GOTU
+$6.67M
3
PARA
Paramount Global Class B
PARA
+$5.77M
4
VIPS icon
Vipshop
VIPS
+$5.57M
5
TME icon
Tencent Music
TME
+$5.35M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.29%
2 Healthcare 13.21%
3 Industrials 11.54%
4 Technology 11.13%
5 Financials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSR
801
DELISTED
Whitestone REIT
WSR
$236K 0.04%
24,372
-7,256
-23% -$65K
NTRP icon
802
NextTrip
NTRP
$24.9M
$236K 0.04%
+3,168
New +$258K
CCLD icon
803
CareCloud
CCLD
$112M
$235K 0.04%
+28,254
New +$279K
PLOW icon
804
Douglas Dynamics
PLOW
$1.02B
$235K 0.04%
+5,091
New +$235K
EIGR
805
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$235K 0.04%
886
-3,632
-80% -$1.14M
WTM icon
806
White Mountains Insurance
WTM
$5.13B
$234K 0.04%
210
-403
-66% -$451K
DVN icon
807
Devon Energy
DVN
$47.3B
$233K 0.04%
10,682
-818
-7% -$16.8K
REKR icon
808
Rekor Systems
REKR
$91.7M
$233K 0.04%
+11,660
New +$174K
IMDX
809
Insight Molecular Diagnostics
IMDX
$156M
$232K 0.04%
2,231
-6,276
-74% -$596K
VTAK icon
810
Catheter Precision
VTAK
$1.01M
$231K 0.04%
+5
New +$327K
TPC
811
Tutor Perini Cor
TPC
$5.21B
$231K 0.04%
12,214
-41,287
-77% -$699K
PCTI
812
DELISTED
PCTEL, Inc. Common Stock
PCTI
$231K 0.04%
33,266
-17,774
-35% -$136K
NH
813
DELISTED
NantHealth, Inc
NH
$230K 0.04%
4,778
-2,977
-38% -$173K
STFC
814
DELISTED
State Auto Financial Corp
STFC
$230K 0.04%
11,675
-17,119
-59% -$315K
GEN icon
815
Gen Digital
GEN
$17.5B
$229K 0.04%
+10,752
New +$225K
MTSC
816
DELISTED
MTS Systems Corp
MTSC
$229K 0.04%
3,937
-363
-8% -$21.3K
INO icon
817
Inovio Pharmaceuticals
INO
$69M
$228K 0.04%
2,047
+473
+30% +$62.2K
MYRG icon
818
MYR Group
MYRG
$5.25B
$228K 0.04%
+3,182
New +$201K
ALNY icon
819
Alnylam Pharmaceuticals
ALNY
$29.3B
$227K 0.04%
+1,610
New +$242K
CDP icon
820
COPT Defense Properties
CDP
$4.21B
$227K 0.04%
+8,640
New +$229K
LSI
821
DELISTED
Life Storage, Inc.
LSI
$227K 0.04%
+2,641
New +$220K
ARCB icon
822
ArcBest
ARCB
$3.08B
$226K 0.04%
+3,210
New +$185K
FENC icon
823
Fennec Pharmaceuticals
FENC
$402M
$226K 0.04%
+36,473
New +$275K
KMB icon
824
Kimberly-Clark
KMB
$36.5B
$226K 0.04%
1,622
-2,959
-65% -$393K
NAV
825
DELISTED
Navistar International
NAV
$226K 0.04%
+5,129
New +$226K

Similar funds

GSA Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, GSA Capital Partners held 1,678 positions worth $603M, down 1.4% from $611M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

GSA Capital Partners withdrew a net $46.2M in Q1 2021, closing 629 positions and reducing 321 holdings. Its most notable exit was Just Eat Takeaway.com N.V. American Depositary Shares, an estimated $3.36M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, GSA Capital Partners opened a new position in Baidu worth $5.94M.

  • GSA Capital Partners's largest Q1 2021 buy was Baidu: 27,291 shares worth $5.94M.
  • GSA Capital Partners added most to Tencent Music in Q1 2021, an estimated $5.35M increase.
  • GSA Capital Partners's biggest Q1 2021 reduction was Medifast, cutting an estimated $2.5M.
  • GSA Capital Partners fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2021, selling an estimated $3.36M.
  • GSA Capital Partners's ten largest holdings make up 7.8% of its $603M portfolio in Q1 2021.
  • GSA Capital Partners opened 527 new positions and closed 629 in Q1 2021.
  • GSA Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $603M.

Based on GSA Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.